Clinical characteristics, outcome and prognostic factors in critically ill patients with lupus nephritis

被引:0
作者
Guo, J. [1 ]
Huang, M. [2 ]
Ren, Z. [3 ]
Huang, Z. [4 ]
Ma, N. [5 ]
Wang, Q. [1 ]
Yin, R. [1 ]
Zhu, Z. [1 ]
Wang, S. [1 ]
Li, T. [1 ]
Liu, S. [1 ]
Yu, Z. [3 ]
机构
[1] Zhengzhou Univ, Dept Rheumatol & Immunol, Affiliated Hosp 1, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Dept Dermatol & Venereal Dis, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Infect Dis, Affiliated Hosp 1, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
[4] Zhengzhou Univ, Dept Cardiovasc Dis, Affiliated Hosp 1, Zhengzhou, Peoples R China
[5] Zhengzhou Univ, Dept Intens Care Unit, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
lupus nephritis; intensive care unit; clinical characteristics; outcome; prognostic factors; GAMMA-GLUTAMYL-TRANSFERASE; INTENSIVE-CARE-UNIT; ERYTHEMATOSUS; MORTALITY; CLASSIFICATION; SURVIVAL; DISEASES; RISK; INFECTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To describe the clinical characteristics and outcome of patients with lupus nephritis (LN) in intensive care unit (ICU), identify prognostic factors and construct a predictive model of in-ICU survival. Methods A total of 505 ICU admissions of lupus patients were screened and LN patients confirmed by renal biopsy were enrolled. Clinical characteristics and outcome of patients in ICU were collected. A logistic regression analysis was performed to identify independent prognostic factors and a nomogram was plotted to construct a predictive model. Results A total of 70 patients with LN were enrolled. The median age of the patients was 28.5 years, and the median course of LN was two months. Renal pathology classes indicated that 38 patients were class IV, 11 were class IV+V, and 10 were class III. The most common primary cause of ICU admission was infection in 40 patients, followed by LN in 11 patients. Forty-one patients died in ICU. The multivariate analyses revealed that lactic acid (OR 1.682 [2.130-17.944], p=0.001), gamma-glutamyl transpeptidase (OR 1.057 [1.009-1.107], p=0.020), APACHE II (OR 3.852 [1.176-12.618], p=0.026), vasopressor (OR 10.571 [1.615-69.199], p=0.014) and platelet count (OR 0.967 [0.941-0.993], p=0.013) were independently associated with ICU survival of critical LN patients. A predictive model was constructed and validated. Conclusion This study is the first to elucidate the features and identify prognostic factors in critically ill patients with LN. These findings could help clinicians to early identify high-risk patients of mortality, which consequently may reduce the mortality of critically ill patients with LN.
引用
收藏
页码:514 / 521
页数:8
相关论文
共 40 条
[1]   Outcome of patients with systemic lupus erythematosus in intensive care unit [J].
Alzeer, AH ;
Al-Arfaj, A ;
Basha, SJ ;
Alballa, S ;
Al-Wakeel, J ;
Al-Arfaj, H ;
Al-Sugair, S ;
Al-Mugeiren, S ;
Al-Shamairi, M ;
Bamgboye, EA .
LUPUS, 2004, 13 (07) :537-542
[2]   Study of critically ill patients with systemic lupus erythematosus [J].
Ansell, SM ;
Bedhesi, S ;
Ruff, B ;
Mahomed, AG ;
Richards, G ;
Mer, M ;
Feldman, C .
CRITICAL CARE MEDICINE, 1996, 24 (06) :981-984
[3]   Mortality in systemic lupus erythematosus [J].
Bernatsky, S. ;
Boivin, J. -F. ;
Joseph, L. ;
Manzi, S. ;
Ginzler, E. ;
Gladman, D. D. ;
Urowitz, M. ;
Fortin, P. R. ;
Petri, M. ;
Barr, S. ;
Gordon, C. ;
Bae, S. -C. ;
Isenberg, D. ;
Zoma, A. ;
Aranow, C. ;
Dooley, M. -A. ;
Nived, O. ;
Sturfelt, G. ;
Steinsson, K. ;
Alarcon, G. ;
Senecal, J. -L. ;
Zummer, M. ;
Hanly, J. ;
Ensworth, S. ;
Pope, J. ;
Edworthy, S. ;
Rahman, A. ;
Sibley, J. ;
El-Gabalawy, H. ;
McCarthy, T. ;
Pierre, Y. St. ;
Clarke, A. ;
Ramsey-Goldman, R. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2550-2557
[4]   Updates on the Treatment of Lupus Nephritis [J].
Bomback, Andrew S. ;
Appel, Gerald B. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (12) :2028-2035
[5]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[6]   Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus [J].
Borchers, AT ;
Keen, CL ;
Shoenfeld, Y ;
Gershwin, ME .
AUTOIMMUNITY REVIEWS, 2004, 3 (06) :423-453
[7]   All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database [J].
Dhital, Rashmi ;
Pandey, Ramesh Kumar ;
Poudel, Dilli Ram ;
Oladunjoye, Olubunmi ;
Paudel, Prakash ;
Karmacharya, Paras .
RHEUMATOLOGY INTERNATIONAL, 2020, 40 (03) :393-397
[8]   Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit [J].
Fatemi, Alimohammad ;
Shamsaee, Somayeh ;
Raeisi, Ahmad ;
Sayedbonakdar, Zahra ;
Smiley, Abbas .
CLINICAL RHEUMATOLOGY, 2017, 36 (11) :2471-2477
[9]   Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients [J].
Gaddnas, Fiia ;
Koskela, Marjo ;
Koivukangas, Vesa ;
Risteli, Juha ;
Oikarinen, Aarne ;
Laurila, Jouko ;
Saarnio, Juha ;
Ala-Kokko, Tero .
CRITICAL CARE, 2009, 13 (02) :R53
[10]   Lupus Nephritis: Is the Kidney Biopsy Currently Necessary in the Management of Lupus Nephritis? [J].
Giannico, Giovanna ;
Fogo, Agnes B. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (01) :138-145